The PICOPLUS from Lutronic has been proven Safe and Effective for the Treatment of Melasma in a recent Split Face Trial

The PICOPLUS has demonstrated safety and efficacy in this well-designed study, which is in line with other articles on the ps-laser in the literature. Additionally, I am excited about the added benefits demonstrated with the use of the combined wavelength approach.

The study authors compared the combined treatment of 2% hydroquinone (HQ) cream and dual wavelength picosecond laser (ps-laser) treatment (1064 nm and 595 nm) (ps-laser + HQ) to using 2% HQ cream alone in a split-face trial protocol. Two percent HQ is already an accepted treatment and was used as the control. The lightness index (LI),as measured objectively by a colorimeter, was used to assess the improvement between the two different treatment sides. The averaged LI scores of the PICOPLUS + HQ sides showed a significant decrease compared with the control HQ-treated sides, denoting an improvement in the melasma lesions. No side effects were reported by patients or clinicians.

In addition to the superior LI scores for the ps-laser + HQ treatment, some other things of note were mentioned: recurrence rates, a consistent problem with melasma treatment, were relatively low: this is thought to be related to the dual wavelength protocol utilized in this study. In addition, there was a noted reduction in erythema as a side effect: this is believed to have a direct correlation to the 595 nm visible yellow wavelength in what Lutronic refers to as PICO gold toning.

“The PICOPLUS has demonstrated safety and efficacy in this well-designed study, which is in line with other articles on the ps-laser in the literature,” stated Dr. Glen Calderhead, VP of Lutronic Medicoscientific Affairs. “Additionally, I am excited about the added benefits demonstrated with the use of the combined wavelength approach.” The reduction in side effects, number of treatments needed and low reoccurrence rates clearly demonstrate the efficacy of the PICOPLUS protocol for treating melasma in Korean skin types.

About PICOPLUS

The PICOPLUS platform offers both picosecond and nanosecond modes with the additional benefit of four wavelengths to provide physicians with more options than ever before to address everything from the standard treatments for pigmented lesions, to those hard-to-treat cases resistant…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *